Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 24, 2022

View Archived Issues

Brain-derived extracellular vesicles participate in the prion-like propagation of tau in tauopathies

EVs and their miRNAs released by inflammatory-primed stem cells may reverse brain inflammation

R8H283 antibody targets multiple myeloma cells through CD98 recognition

GSNOR deficiency tied to pre-eclampsia

CAR T cells targeting GRP78 show activity against acute myeloid leukemia in vivo

Sanofi patents YAP1/TAZ and TEAD interaction inhibitors

Adorx Therapeutics discloses adenosine receptor A2A and/or A2B antagonists

Prodrugs of clopidogrel's active metabolite identified by Shanghai Curegene Pharmaceutical

Femtogenix discovers new antibody-drug conjugates for cancer

Merck & Co. synthesizes new influenza virus Cap-dependent endonuclease inhibitors

v7D, varicella vaccine candidate with promising safety and immunogenicity in nonhuman primates

Financing at Plexium supports progression of pipeline of targeted protein degradation therapies

Jnana selects JNT-517 as development candidate for phenylketonuria

ConserV receives funding to advance pan-coronavirus vaccine candidate UNICOR-v

Identification of novel antifungal and antibacterial compounds

IL-9/ARG1/macrophage axis targeting for the treatment of allergic airway inflammation

GliaPharm and Wyss Center collaborate on new treatments for Alzheimer's disease

Risk SNP for COVID-19 signals protection against HIV

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...